These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23312576)

  • 21. [Prenatal diagnosis of oculocutaneous albinism type IV and discovery of a novel mutation].
    Pang T; Lei J; Zheng H; Xu B; Jiang WY; Li HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):1-5. PubMed ID: 21287499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
    Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
    J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
    Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
    N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prenatal diagnosis of oculocutaneous albinism type II and discovery of two novel mutations].
    Li HY; Wei HY; Zheng H; Meng S; Jiang WY; Chen LM; Duan HL
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1123-5. PubMed ID: 17672996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A patient with subclinical oculocutaneous albinism type 2 diagnosed on getting severely sunburned.
    Kawai M; Suzuki T; Ito S; Inagaki K; Suzuki N; Tomita Y
    Dermatology; 2005; 210(4):322-3. PubMed ID: 15942220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inheritance of a novel mutated allele of the OCA2 gene associated with high incidence of oculocutaneous albinism in a Polynesian community.
    Johanson HC; Chen W; Wicking C; Sturm RA
    J Hum Genet; 2010 Feb; 55(2):103-11. PubMed ID: 20019752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
    Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
    Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal molecular diagnosis of oculocutaneous albinism (OCA) in a large cohort of Israeli families.
    Rosenmann A; Bejarano-Achache I; Eli D; Maftsir G; Mizrahi-Meissonnier L; Blumenfeld A
    Prenat Diagn; 2009 Oct; 29(10):939-46. PubMed ID: 19626598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid genetic analysis of oculocutaneous albinism (OCA1) using denaturing high performance liquid chromatography (DHPLC) system.
    Lin SY; Chien SC; Su YN; Lee CN; Chen CP
    Prenat Diagn; 2006 May; 26(5):466-70. PubMed ID: 16570240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of familial trichomegaly in association with oculocutaneous albinism type 1.
    Ziakas NG; Jogiya A; Michaelides M
    Eye (Lond); 2004 Aug; 18(8):863-4. PubMed ID: 14752500
    [No Abstract]   [Full Text] [Related]  

  • 32. Gene symbol: TYR. Disease: Albinism, oculocutaneous 1.
    Patrosso MC; Lando G; Penco S
    Hum Genet; 2008 Oct; 124(3):294. PubMed ID: 18846608
    [No Abstract]   [Full Text] [Related]  

  • 33. PMEL is mutated in oculocutaneous albinism.
    AlAbdi L; Alshammari M; Helaby R; Khan AO; Alkuraya FS
    Hum Genet; 2023 Jan; 142(1):139-144. PubMed ID: 36166100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional characterization of natural human melanocortin 1 receptor mutant alleles in Pakistani population.
    Shahzad M; Sires Campos J; Tariq N; Herraiz Serrano C; Yousaf R; Jiménez-Cervantes C; Yousaf S; Waryah YM; Dad HA; Blue EM; Sobreira N; López-Giráldez F; ; Kausar T; Ali M; Waryah AM; Riazuddin S; Shaikh RS; García-Borrón JC; Ahmed ZM
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):730-5. PubMed ID: 26197705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetics of oculocutaneous albinism.
    Spritz RA
    Semin Dermatol; 1993 Sep; 12(3):167-72. PubMed ID: 8217557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oculocutaneous albinism].
    Lacour JP; Ortonne JP
    Ann Pediatr (Paris); 1992 Sep; 39(7):409-18. PubMed ID: 1416662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oculocutaneous albinism, immunodeficiency, hematological disorders, and minor anomalies: a new autosomal recessive syndrome?
    Kotzot D; Richter K; Gierth-Fiebig K
    Am J Med Genet; 1994 Apr; 50(3):224-7. PubMed ID: 8042664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on TYR gene variant from a pedigree with oculocutaneous albinism].
    Zhang Y; Jin C; Guo M; Li D; Chai L; Wu Y; Li D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Sep; 38(9):833-837. PubMed ID: 34487524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consanguinity and disease coincidence.
    Buchan JC; Bradbury JA; Sheridan E
    Eye (Lond); 2003 Mar; 17(2):280-2. PubMed ID: 12640435
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular characterization of SLC24A5 variants and evaluation of Nitisinone treatment efficacy in a zebrafish model of OCA6.
    Yousaf S; Sethna S; Chaudhary MA; Shaikh RS; Riazuddin S; Ahmed ZM
    Pigment Cell Melanoma Res; 2020 Jul; 33(4):556-565. PubMed ID: 32274888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.